Histone deacetylases and their inhibitors in inflammatory diseases
Sen-Yu Zhang, Liying Zhang, Ri Wen, Ni Yang, Tie‐Ning Zhang
Abstract
Despite considerable research efforts, inflammatory diseases remain a heavy burden on human health, causing significant economic losses annually. Histone deacetylases (HDACs) play a significant role in regulating inflammation (via histone and non-histone protein deacetylation) and chromatin structure and gene expression regulation. Herein, we present a detailed description of the different HDACs and their functions and analyze the role of HDACs in inflammatory diseases, including pro-inflammatory cytokine production reduction, immune cell function modulation, and anti-inflammatory cell activity enhancement. Although HDAC inhibitors have shown broad inflammatory disease treatment potentials, their clinical applicability remains limited because of their non-specific effects, adverse effects, and drug resistance. With further research and insight, these inhibitors are expected to become important tools for the treatment of a wide range of inflammatory diseases. This review aims to explore the mechanisms and application prospects of HDACs and their inhibitors in multiple inflammatory diseases. • HDACs are crucial in inflammatory response regulation. • HDACs affect inflammatory gene transcription and immune cell function. • HDACs are important targets for inflammatory disease treatment. • Different HDAC inhibitors regulate inflammatory responses via various mechanisms. • HDAC inhibitor research should provide guidance for effective drug development.